Add BrightSurf on Google Email

Recognizing the evolution of clinical syndrome spectrum progression in individuals with single large-scale mitochondrial DNA deletion syndromes (SLSMDS))

A retrospective natural history study of 30 patients with single large-scale mitochondrial DNA deletion syndromes (SLSMD) reveals a broader clinical presentation than previously thought. The study identifies key molecular details, including a recurrent deleted region in the MT-ND5 gene and elevated levels of biomarker GDF-15.

SourceChildren's Hospital of Philadelphia·JournalGenetics in Medicine·DateFeb 20, 2025

New toolkit empowers healthcare providers with evidence-based strategies for childhood obesity prevention and treatment

The Childhood Obesity Prevention, Evaluation and Treatment Toolkit provides healthcare providers with practical guidance for preventing, evaluating, and treating childhood obesity. The toolkit is grounded in scientific evidence and offers actionable treatment approaches for children and adolescents dealing with overweight and obesity.

Children with ARFID face increased risk of disease

A new study found that children with avoidant restrictive food intake disorder (ARFID) are at a higher risk of developing intellectual disability, autism, gastro-oesophageal reflux disease, epilepsy, and chronic lung diseases. They also experience more medical diagnoses and require longer hospital stays than other children.

SourceKarolinska Institutet·JournalJAMA Pediatrics·TypeObservational study·DateFeb 17, 2025

Eating gradually increasing doses of store-bought peanut butter enables children with high-threshold allergy to safely consume peanuts

A new study led by researchers at Mount Sinai Hospital found that children with high-threshold peanut allergy can be treated with a safe and effective approach, allowing them to tolerate larger doses of peanut butter. The treatment involves gradually increasing doses over 18 months, resulting in sustained unresponsiveness to peanuts fo...

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNEJM Evidence·TypeExperimental study·DateFeb 10, 2025

Therapy helps peanut-allergic kids tolerate tablespoons of peanut butter

Researchers report that eating increasingly higher doses of peanut butter enabled 100% of children with peanut allergy who initially tolerated half a peanut to consume three tablespoons without an allergic reaction. The therapy could potentially fulfill an unmet need for about half of children with peanut allergy, who already can toler...

Children’s Hospital of Philadelphia researchers lead first study to identify molecular basis of food allergy

A multi-institutional study identified the specific milk protein triggering a patient's case of eosinophilic esophagitis, an inflammatory disease of the esophagus. The findings represent the first time any research team has described molecular details of food antigen recognition in EoE.

SourceChildren's Hospital of Philadelphia·JournalJournal of Allergy and Clinical Immunology·TypeExperimental study·DateFeb 3, 2025

Long COVID, Italian scientists discovered the molecular ‘fingerprint’ of the condition in children's blood

A study by Italian scientists has identified a distinct protein signature in the blood plasma of pediatric patients with Long COVID, characterized by increased inflammation and endothelial damage. The discovery could lead to the development of a simple diagnostic test based on a blood sample.

SourceUniversita Cattolica del Sacro Cuore·JournalPediatric Research·TypeObservational study·DateJan 24, 2025

Treatment for children with obesity has lasting effect

A study published in JAMA Pediatrics found that childhood obesity treatment can reduce the risk of serious health problems such as type 2 diabetes, hypertension, and dyslipidaemia in young adults. However, it did not have a lasting impact on depression and anxiety, which remained unchanged regardless of treatment outcomes.

SourceKarolinska Institutet·JournalJAMA Pediatrics·TypeObservational study·DateJan 21, 2025

Dr. Jennifer Jao named Co-Chair of International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) Network

Dr. Jennifer Jao has been selected as Co-Chair of the International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) Network to guide critical work in improving HIV health outcomes globally. Dr. Jao's research focuses on pregnant individuals, children, and adolescents with perinatally acquired HIV.

Using AI to uncover hospital patients’ long COVID care needs

A new AI system analyzed electronic health records of long-COVID patients to identify four sub-populations with specific needs, including those with asthma or mental health conditions. The study found that these sub-populations require more specialized care and pointed toward updated profiles for hospitals to better address their needs.

SourceUniversity of Pennsylvania School of Medicine·JournalPatterns·TypeData/statistical analysis·DateJan 10, 2025

Synthetic chemicals and chemical products require a new regulatory and legal approach to safeguard children’s health

A report by the Consortium for Children's Environmental Health calls for new laws to test chemicals for safety and toxicity before they enter markets. The authors propose a more precautionary approach to prioritize health protection over unconstrained production of synthetic chemicals and plastics.

SourceBoston College·JournalNew England Journal of Medicine·TypeData/statistical analysis·DateJan 8, 2025

Fluoride exposure and children’s IQ scores

A systematic review and meta-analysis found an inverse association between fluoride exposure and children's IQ scores. The findings suggest a dose-response relationship between fluoride levels and IQ across multiple countries, highlighting the need for comprehensive public health risk-benefit assessments of fluoride exposures.

SourceJAMA Network·JournalJAMA Pediatrics·DateJan 6, 2025

TNF inhibitors prevent complications in kids with Crohn's disease, recommended as first-line therapies

Early treatment with TNF inhibitors has been shown to prevent complications in kids with Crohn's disease, reducing the risk of perianal fistulas by 82%. The study found that anti-TNF drugs are specifically effective in preventing these debilitating complications, making them a recommended first-line therapy.

SourceMichigan Medicine - University of Michigan·JournalGut·TypeObservational study·DateDec 23, 2024

Journal of Dental Research publishes study exploring the impact of early childhood exposure to fluoride on cognitive neurodevelopment

A recent study published in Journal of Dental Research examined the relationship between early childhood fluoride exposure and cognitive development. The research found that there were no significant effects of fluoride exposure on cognitive neurodevelopment, with the hypothesis of non-inferiority tests also supporting this conclusion.

A simple plasma-based biomarker could predict liver fibrosis in Latino adolescents with obesity

Researchers discovered a novel combination of plasma-based biomarkers that can predict liver fibrosis in Latino adolescents with obesity. The study found that dihydroxyacetone phosphate (DHAP) and alanine transaminase (ALT) were significantly associated with fibrosis, suggesting a potential low-cost, noninvasive screening tool.

SourceChildren's Hospital Los Angeles·JournalJournal of Pediatric Gastroenterology and Nutrition·TypeExperimental study·DateDec 16, 2024

Children’s Hospital of Philadelphia, Stanford Researchers reveal and refine new immunotherapy platform with increased potential to target cancer cells

Researchers at Children's Hospital of Philadelphia and Stanford University have developed a new immunotherapy platform called TRACeR-I, which can more accurately recognize a wide variety of surface proteins expressed by cancer cells. This improved recognition enables the body's own immune system to target cancer cells more effectively.

SourceChildren's Hospital of Philadelphia·JournalNature Biotechnology·TypeExperimental study·DateDec 13, 2024